Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.1402 | 0.1846 | 0.0894 | |
Leishmania major | AMP deaminase, putative | 0.1721 | 0.3297 | 0.2514 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Mycobacterium leprae | PROBABLE OXIDOREDUCTASE | 0.1402 | 0.1846 | 0.1846 |
Loa Loa (eye worm) | hypothetical protein | 0.197 | 0.4426 | 0.3776 |
Plasmodium falciparum | adenosine deaminase | 0.3196 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Echinococcus multilocularis | adenosine deaminase | 0.3196 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Onchocerca volvulus | 0.1402 | 0.1846 | 0.0894 | |
Trypanosoma cruzi | aldo-keto reductase | 0.1402 | 0.1846 | 0.3557 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Onchocerca volvulus | 0.1402 | 0.1846 | 0.0894 | |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Leishmania major | prostaglandin f2-alpha synthase/D-arabinose dehydrogenase | 0.1402 | 0.1846 | 0.0894 |
Loa Loa (eye worm) | oxidoreductase | 0.1402 | 0.1846 | 0.0894 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.3196 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Leishmania major | AMP deaminase, putative,amp deaminase-like protein | 0.1721 | 0.3297 | 0.2514 |
Echinococcus multilocularis | AMP deaminase 2 | 0.1721 | 0.3297 | 0.3297 |
Entamoeba histolytica | adenosine deaminase, putative | 0.3196 | 1 | 1 |
Leishmania major | AMP deaminase, putative,adenosine monophosphate deaminase-like protein | 0.1721 | 0.3297 | 0.2514 |
Leishmania major | adenosine monophosphate deaminase, putative,AMP deaminase, putative | 0.1721 | 0.3297 | 0.2514 |
Echinococcus multilocularis | aldo keto reductase | 0.1402 | 0.1846 | 0.1846 |
Onchocerca volvulus | 0.1402 | 0.1846 | 0.0894 | |
Onchocerca volvulus | 0.1402 | 0.1846 | 0.0894 | |
Echinococcus multilocularis | aldo keto reductase | 0.1402 | 0.1846 | 0.1846 |
Plasmodium vivax | adenosine deaminase, putative | 0.3196 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.197 | 0.4426 | 0.3776 |
Entamoeba histolytica | AMP deaminase, putative | 0.1721 | 0.3297 | 0.1779 |
Schistosoma mansoni | adenosine deaminase-related | 0.3196 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.3196 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Trypanosoma brucei | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Trypanosoma brucei | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.3196 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.1402 | 0.1846 | 0.1846 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.3196 | 1 | 1 |
Trypanosoma brucei | adenosine monophosphate deaminase, putative | 0.1721 | 0.3297 | 1 |
Giardia lamblia | Aldose reductase | 0.1402 | 0.1846 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.197 | 0.4426 | 0.3776 |
Echinococcus granulosus | hypothetical protein | 0.1402 | 0.1846 | 0.1846 |
Trypanosoma brucei | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Trypanosoma cruzi | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.1402 | 0.1846 | 0.1846 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Loa Loa (eye worm) | hypothetical protein | 0.1402 | 0.1846 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.197 | 0.4426 | 0.3776 |
Echinococcus granulosus | aldo keto reductase | 0.1402 | 0.1846 | 0.1846 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.3196 | 1 | 1 |
Schistosoma mansoni | adenosine deaminase | 0.3196 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Trypanosoma cruzi | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.1402 | 0.1846 | 0.1846 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Entamoeba histolytica | AMP deaminase, putative | 0.1721 | 0.3297 | 0.1779 |
Leishmania major | aldo-keto reductase-like protein | 0.1402 | 0.1846 | 0.0894 |
Loa Loa (eye worm) | oxidoreductase | 0.1402 | 0.1846 | 0.0894 |
Toxoplasma gondii | AMP deaminase | 0.1721 | 0.3297 | 0.1779 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.3196 | 1 | 1 |
Leishmania major | prostaglandin f synthase, putative | 0.1402 | 0.1846 | 0.0894 |
Loa Loa (eye worm) | hypothetical protein | 0.3196 | 1 | 1 |
Loa Loa (eye worm) | AMP deaminase | 0.1721 | 0.3297 | 0.2514 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Treponema pallidum | adenosine deaminase | 0.3196 | 1 | 0.5 |
Trypanosoma cruzi | aldo/keto reductase, putative | 0.1402 | 0.1846 | 0.3557 |
Brugia malayi | adenosine monophosphate deaminase | 0.1721 | 0.3297 | 0.1779 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Onchocerca volvulus | 0.1402 | 0.1846 | 0.0894 | |
Leishmania major | aldehyde reductase, putative,oxidoreductase, putative | 0.1402 | 0.1846 | 0.0894 |
Echinococcus multilocularis | aldo keto reductase | 0.1402 | 0.1846 | 0.1846 |
Echinococcus granulosus | adenosine deaminase | 0.3196 | 1 | 1 |
Trypanosoma cruzi | adenosine monophosphate deaminase-like protein, putative | 0.1721 | 0.3297 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Trypanosoma cruzi | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Echinococcus granulosus | AMP deaminase 2 | 0.1721 | 0.3297 | 0.3297 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.3196 | 1 | 1 |
Mycobacterium ulcerans | adenosine deaminase | 0.3196 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.1402 | 0.1846 | 0.1846 |
Loa Loa (eye worm) | oxidoreductase | 0.1402 | 0.1846 | 0.0894 |
Trypanosoma cruzi | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Onchocerca volvulus | AMP deaminase 2 homolog | 0.1721 | 0.3297 | 0.2514 |
Loa Loa (eye worm) | oxidoreductase | 0.1402 | 0.1846 | 0.0894 |
Giardia lamblia | Aldose reductase | 0.1402 | 0.1846 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.1402 | 0.1846 | 0.1846 |
Trypanosoma cruzi | AMP deaminase, putative | 0.1721 | 0.3297 | 1 |
Leishmania major | adenine aminohydrolase | 0.3196 | 1 | 1 |
Entamoeba histolytica | adenosine deaminase, putative | 0.3196 | 1 | 1 |
Trypanosoma cruzi | adenosine monophosphate deaminase, putative | 0.1721 | 0.3297 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.1402 | 0.1846 | 0.0894 |
Schistosoma mansoni | AMP deaminase | 0.1721 | 0.3297 | 0.1779 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.03 uM | Inhibition of AP-1 and NF-kB mediated transcriptional activation in Jurkat T-cells | ChEMBL. | 14592511 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.